News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Gilberto Lopes, MD, MBA, FAMS

Articles by Gilberto Lopes, MD, MBA, FAMS

32 Impact of Comorbid HIV Infection on Breast Cancer Time to Treatment and Chemotherapy Relative Dose Intensity

ByElizabeth Rubin,Philippos Costa,Michael H. Antoni,Judith Hurley, MD,Gilberto Lopes, MD, MBA, FAMS,Danial S O’Neil

April 18th 2022

Gilberto Lopes, MD, MBA, FAMS, on Stopping Immunotherapy in Patients With Lung Cancer

ByGilberto Lopes, MD, MBA, FAMS

February 21st 2020

Gilberto Lopes, MD, MBA, FAMS, discussed his presentation about when to stop immunotherapy treatments for patients with lung cancer.

Latest Updated Articles

32 Impact of Comorbid HIV Infection on Breast Cancer Time to Treatment and Chemotherapy Relative Dose Intensity
April 18th 2022
Gilberto Lopes, MD, MBA, FAMS, on Stopping Immunotherapy in Patients With Lung Cancer
February 21st 2020

Trending on CancerNetwork

Toxicity From CD19, BCMA Therapy May Inform B-Cell Malignancy Surveillance

Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer

Nogapendekin Alfa Plus BCG Exhibits Efficacy Advantage in NMIBC In Situ

Fianlimab Combo Does Not Significantly Improve PFS in Advanced Melanoma

105 Real-World Overall Survival With Palbociclib Plus an Aromatase Inhibitor (AI) in Overweight/Obese Patients With HR+/HER2− Metastatic Breast Cancer (MBC)